Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: Unknown
Life Threatening? No
Write-up: This case was reported by the agency on 12-MAY- 2011, reference ADR21045923. This case is medically confirmed. A 12 year old female patient received GARDASIL (manufacturer and batch not reported, intramuscularly 0.5ml on 10-OCT-2010. An unreported time post vaccination, the patient experienced chronic pain syndrome, chronic fatigue and neuropathic pain. The events were ongoing at the time of reporting to the agency (also reported as outcome unknown). The patient underwent extensive testing for pain with normal results. The patient was born with facial lymphangioma and had a history of laser therapy in July 2010. The patient was taking concomitant medications of fentanyl transdermally for pain since August 2010 and salbutamol for asthma since 2008. The reporter felt the events were medically significant: chronic pain, difficulty mobilizing, off school. The serious criterion of disability was also selected. Other business partner numbers included E2011-02927. No further information is available.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166